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ABSTRACT 
 
Objectives 
Bacterial infections in the normally sterile environment of the middle ear cavity 
usually trigger host immune response, whereby the innate immune system plays 
a dominant role as the host’s first line of defense. In this study we evaluated the 
expression levels of Toll-like receptors (TLRs) -2, -4, -5, -9, and nucleotide-
binding oligomerization domain-containing proteins (NODs) -1 and -2, all of which 
are related to bacterial infection in pediatric patients with otitis media with 
effusion (OME).   
 
Methods 
The study sample consisted of 46 pediatric patients with OME, all of whom had 
ventilation tubes inserted. The expression levels of TLR-2, -4, -5, -9, NOD-1 and 
-2 mRNA in middle ear effusion were assessed by polymerase chain reaction. 
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Results  
All effusion fluid samples collected from patients with OME showed expression of 
TLR-2, -4, -5, -9, NOD-1, and -2 mRNA. However, we found no correlations 
among expression levels of pattern recognition receptors (PRRs) in relation to 
characteristics of exudates, presence of bacteria, or frequencies of ventilation 
tube insertion (p>0.05). 
 
Conclusion 
Our findings suggest that exudates of OME patients show PRR expressions that 
are related to the innate immune response regardless of the characteristics of 
effusion fluid, presence of bacteria in exudates, or frequency of ventilation tube 
insertion.  
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 1 
INTRODUCTION 
 
Otitis media with effusion 
 Otitis media with effusion (OME) is defined as the presence of fluid in 
the middle ear without signs or symptoms of acute ear infection, and is 
associated with bacterial infections of the upper respiratory tract and dysfunction 
of the Eustachian tubes (Figure 1) (1). The Eustachian tubes equalize the 
pressure between the middle ear cavity and the outside atmosphere and allow 
fluid and mucus to drain out of the middle ear cavity. In case of inflammation the 
tube closes causing the fluid to become trapped. Bacteria from the back of the 
nose travel through the Eustachian tube directly into the middle ear cavity and 
multiply in the fluid. The tympanic membrane is often cloudy with distinctly 
impaired mobility, and an air-fluid level or bubble may be visible in the middle ear 
(Figure 2). The development of more effective treatment is complicated by the 
fact the OME seems to be a multifactorial disease. Obstruction of the Eustachian 
tube with resultant negative pressure and exudation of serum seems to be a 
major factor (2). Bacterial infection via the Eustachian tube, perhaps facilitated by 
the presence of serum as a growth medium, is also well-recognized as a 
component in this complex etiology. OME is also strongly associated with prior 
upper respiratory viral infection (3), which increases the likelihood of subsequent 
bacterial middle ear infection for reasons that are unclear but could include 
increased bacterial adherence in the nasopharynx and reduced ciliary activity in 
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the Eustachian tube. Inflammatory reactions associated with immune response to 
bacterial antigens, bacterial polysaccharides, and disorders of inflammatory 
pathways, such as the cytokine network and the complement cascade, may also 
contribute to OME pathogenesis, especially in its chronic forms. Several other 
factors may also be involved in the development of OME, including the host 
immune system, environmental factors, family history, allergies, adenoid 
hypertrophy, chronic sinusitis, cleft palate, tumors, or even sharp changes in 
atmospheric pressure. Recently, it was reported that in many cases of OME, 
bacteria or viruses are found in middle ear effusion.  
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Figure 1. Structures of the Ear. Figure taken from Merriam-Webster, 2013 (51).  
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Figure 2. Middle ear infection: Otitis media with effusion. Figure taken from 
A.D.A.M. Inc., the American Accreditation HealthCare Commission 
(www.urac.org), 2013 (52). 
  
 OME can be detected by examining the ear with pneumatic otoscopy. 
Diagnosis can be confirmed only by directly looking in the ear and seeing how 
the eardrum responds to gentle pressure. In addition, two tests may be 
performed to give the doctor information that cannot be learned through 
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observation only. One of these tests is an audiogram, in which tones are 
sounded at various pitches. An audiogram is used to measure how much hearing 
loss has occurred. The other test, called a tympanogram, measures the air 
pressure in the middle ear; this indicates how well the Eustachian tube is 
functioning. In recurrent cases or when and acute case does not respond to 
treatment, it may be necessary to obtain a culture from the middle ear, through 
the eardrum. This is usually achieved by an otolaryngologist. 
 About 2.2 million diagnosed episodes of OME occur annually in the 
United States, yielding a combined direct and indirect annual cost estimate of 
$4.0 billion (4). OME is highly prevalent in young children. Studies show that 
about 90% of children (80% of individual ears) have OME at some time before 
school age, most often between ages 6 months and 4 years (5,6). In the first year 
of life, more than 50% of children will experience OME, increasing to more than 
60% by age 2 years (7). The primary outcomes include hearing loss, effects on 
speech, language and learning, physiologic sequelae, health care utilization 
(medical, surgical), and quality of life (4,8). Therefore, it is important to 
distinguish children with OME who is at risk for speech, language, or learning 
problems from other children (Table 1.) 
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• Permanent hearing loss independent of otitis media with effusion 
• Suspected or diagnosed speech and language delay or disorder 
• Autism-spectrum disorder and other pervasive developmental disorders 
• Syndromes (e.g. Down) or craniofacial disorders that include cognitive, 
speech and language delays 
• Blindness or uncorrectable visual impairment 
• Cleft palate, with or without associated syndrome 
• Developmental Delay 
 
Table 1. Risk factors for developmental difficulties* 
 
*Sensory, physical cognitive, or behavioral factors that place children who have 
otitis media with effusion at increased risk for developmental difficulties (delay or 
disorder). Data taken from Rosenfeld et al, 2004 (#). 
 
 
 Treatment for OME is appropriate only if persistent and clinically 
significant benefits can be achieved beyond spontaneous resolution. Although 
statistically significant benefits have been demonstrated for some antibiotic 
medications, they are short term and relatively small in magnitude (1). Moreover, 
significant adverse events may occur with all medical therapies. Only for more 
serious, exacerbated OME is antibiotic therapy currently prescribed. Persistent, 
recurrent, and chronic forms of OME affect about 15% of children and represent 
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a more difficult problem. If a child becomes a surgical candidate, ventilation tubes 
can be effective in the treatment of chronic/recurrent OME, but they are not 
always effective and there is controversy regarding long-term benefit and the 
potential for late adverse outcomes such as tympanic membrane abnormalities. 
Surgical candidacy for OME depends largely on hearing status, associated 
symptoms, the child’s developmental risk, and the anticipated chance of timely 
spontaneous resolution of the effusion (1). Candidates for surgery include 
children with OME lasting 4 months or longer with persistent hearing loss or other 
signs and symptoms, recurrent or persistent OME in children at risk regardless of 
hearing status, and OME and structural damage to the tympanic membrane or 
middle ear (1). Ultimately the recommendation for medical and surgical care 
must be individualized, based on consensus between the primary care physician, 
otolaryngologist, and parent or caregiver that a particular child would benefit from 
intervention. 
 Since pediatric patients with OME often have previous histories of 
acute otitis media (AOM); OME is often regarded as the same disease as AOM 
(9). However, OME is considered distinct from acute otitis media (AOM), which is 
defined as a history of acute onset of signs and symptoms, the presence of 
middle-ear effusion, and signs and symptoms of middle-ear inflammation (1). 
AOM typically resolves swiftly, but patients suffering from chronic, recurrent otitis 
media may suffer long-term conductive hearing loss and permanent hearing loss 
due to scarring of the middle ear conductive apparatus and sensorineural 
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damage to the inner ear (10).  Therefore, understanding the infections involved in 
AOM and following the immune response in the middle ear cavity are critical to 
determining the pathophysiological mechanism of OME. 
 
Pathogen Recognition and Innate Immunity 
 The human body is constantly threatened by pathogens such as 
viruses, bacteria, fungi and parasites that are inhaled, swallowed, or inhabit our 
skin and mucous membranes. In cases of infection the immune system, an 
interactive network of lymphoid organism cells, humoral factors, and cytokines, 
play an essential function as the host defense mechanism to protect our body 
(11). Immunity is divided into two parts determined by the speed and specificity 
of the reaction. These are named the innate or adaptive immune system, or a 
cooperative interaction of both that release various immunological mediators. 
The innate immune system is sometimes used to include physical, chemical, and 
microbiological barriers, but more usually encompasses the elements of the 
immune system (neutrophils, monocytes, macrophages, complement, cytokines, 
and acute phase proteins) (11). The innate immune system is considered the first 
line of defense during the host response to pathogens that is mediated by 
phagocytes including macrophages and dendritic cells, and the body 
discriminates infectious non-self from noninfectious self-based on the recognition 
of general patterns (12,13). Acquired immunity is involved in elimination of 
pathogens in the late phase of infection as well as the generation of 
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immunological memory. Acquired immunity is characterized by specificity and 
develops by clonal selection from a vast repertoire of lymphocytes bearing 
antigen-specific receptors that are generated via a mechanism generally known 
as gene rearrangement (12).  
 The innate immune system recognizes microorganisms via a limited 
number of germline-encoded pattern recognition receptors (PRRs). PRRs 
present common characteristics. First, PRRs recognize conserved molecular 
structures termed pathogen-associated molecular patterns (PAMPs) to sense the 
presence of microbial infections (14). Examples are lipopolysaccharide (LPS), 
lipotechoic acid, and mannans on gram negative, gram positive, and yeast cell 
walls, respectively. Second, PRRs are expressed constitutively in the host and 
detect the pathogens regardless of their life-cycle stage. Third, PRRs are 
germline encoded, nonclonal, expressed on all cells of a given type, and 
independent of immunologic memory (12). Furthermore, PRRs fall into three 
groups depending on function; those inducing endocytosis and thus enhancing 
antigen presentation; those initiating nuclear factor κβ transduction and cell 
activation (TLRs) and those, for example mannan binding lectin, which are 
secreted acting as opsonins (11).  
 Different PRRs react with specific PAMPs, show distinct expression 
patterns, activate specific signaling pathways, and lead to distinct antipathogen 
responses. The basic machineries underlying innate immune recognition are 
highly conserved among species, from plants and fruit flies to mammals. The 
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increasing knowledge of these recognition pathways highlights the close relation 
between the innate and specific response—PRRs recognize broad patterns on 
microbes and then presents the processed product to antigen-specific T cells 
(11).  
 
Toll-like receptors (TLRs)  
 PRRs in humans include Toll-like receptors (TLRs) and cytoplasmic 
nucleotide-binding oligomerization domain-like receptors (NLRs). Toll, the 
founding member of the TLR family, was originally identified as a Drosophila 
gene required for ontogenesis and antimicrobial resistance (15). A human Toll 
homolog or human TLRs were then identified and found to induce cytokine 
production and expression of costimulatory molecules. To date, 12 members of 
the TLR family have been identified in mammals. TLRs are type 1 integral 
membrane glycoproteins characterized by the extracellular domains containing 
varying numbers of leucine-rich-repeat (LRR) motifs and a cytoplasmic signaling 
domain homologous to that of the interleukin 1 receptor (IL-1R) (16). Based on 
the primary sequences, TLRs can be further divided into several subfamilies, 
each of which recognizes related PAMPs: the subfamily of TLR1, TLR2, and 
TLR6 recognize lipids, whereas the highly related TLR7, TLR8, and TLR9 
recognize nucleic acids (Table 1). However, the TLRs are unusual in that some 
can recognize several structurally unrelated ligands. For example, TLR 4 
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recognizes a very divergent collection of ligands such as LPS and heat-shock 
proteins (12). 
 
Microbial Components Species TLR Usage 
Bacteria 
LPS Gram-negative bacteria TLR4 
Diacyl lipopeptides Mycoplasma TLR6/TLR2 
Triacyl lipopeptides Bacteria and mycobacteria TLR1/TLR2 
LTA Group B Streptococcus TLR6/TLR2 
PG Gram-positive bacteria TLR2 
Porins Neisseria TLR2 
Lipoarabinomannan Mycobacteria TLR2 
Flagellin Flagellated bacteria TLR5 
CpG-DNA Bacteria and mycobacteria TLR9 
ND Uropathogenic bacteria TLR11 
Fungus 
  Zymosan Saccharomyces cerevisiae TLR6/TLR2 
Phospholipomannan Candida albicans TLR2 
Mannan Candida albicans TLR4 
Glucuronoxylomannan Cryptococcus neoformans TLR2 and TLR4 
Parasites 
  tGPI-mutin Trypanosoma TLR2 
Glycoinositolphospholipids Trypanosoma TLR4 
Hemozoin Plasmodium TLR9 
Profilin-like molecule Toxoplasma gondii TLR11 
Viruses 
  DNA Viruses TLR9 
dsRNA Viruses TLR3 
ssRNA RNA viruses TLR7 and TLR8 
Envelope proteins Respiratory syncytial virus TLR4 
Hemagglutinin protein Measles virus TLR2 
Host 
  Heat-shock protein 60, 70 
 
TLR4 
Fibrinogen 
 
TLR4 
 
Table 2. Toll-like receptor (TLR) recognition of Microbial Components.  
Data taken from Akira, Uematsu, and Takeuchi, 2006 (12). 
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 The engagement of TLRs by microbial components triggers the 
activation of signaling cascades, leading to the induction of genes involved in 
antimicrobial host defense. After ligand binding, TLRs dimerize and undergo 
conformational changes required for the recruitment of TIR-domain-containing 
adaptor molecules to the TIR domain of TLR. There are four adaptor molecules, 
namely MyD88, TIR-associated protein (TIRAP)/MyD88-adaptor-like (MAL), TIR-
domain-containing adaptor protein-inducing IFN-β (TRIF)/TIR-domain-containing 
molecule 1 (TICAM1) (17,18), and TRIF-related adaptor molecule (TRAM). The 
differential responses mediated by distinct TLR ligands can be explained in part 
by the selective usage of these adaptor molecules. MyD88 and TRIF are 
responsible for the activation of distinct signaling pathways, leading to the 
production of proinflammatory cytokines and type 1 IFNs, respectively (12). 
 TLRs and IL-1R share common signaling pathways in general. 
Stimulation with their ligands recruits TIR-domain-containing adaptors including 
MYD88 and TIRAP to the receptor, and the subsequent formation of a complex 
of IL-1R-associated kinases (IRAKs), TNFR-associated factor 6 (TRAF6), and 
IRF-5 is induced. TRAF6 acts as an E3 ubiquitin ligase and catalyzes the K63-
linked polyubiquitin chain on TRAF6 itself and IKK-γ/NF-κβ essential modulator 
(NEMO) with E2 ubiquitin ligase complex of UBC13 and UEV1A. This 
ubiquitination activates the TGF-β-activated kinase 1 (TAK1) complex, resulting 
in the phosphorylation of NEMO and activation of the IKK complex. 
Phosphorylated Iκβ undergoes K28-linked ubiquination and degradation by the 
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proteasome. Freed NF-κβ translocates into the nucleus and initiates the 
expression of proinflammatory cytokine genes. Simultaneously, TAK1 activates 
the MAP kinase cascades, leading to the activation of AP-1, which is also critical 
for the induction of cytokine genes. TLR4 triggers the MyD88 independent, TRIF-
dependent signaling pathway via TRAM to induce type 1 IFNs. TRIF activates 
NF-κβ and IRF-3 resulting in the induction of proinflammatory cytokine genes and 
type 1 IFNs, TRAF6 and RIP1 induce NF-κβ activation and TBK1/IKK-I 
phosphyrylate IRF-3, which induces the translocation of IRF-3 (Figure 3). 
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Figure 3. The Toll-like receptor(TLR) signaling pathway.  
Figure taken from Akira, Uematsu, and Takeuchi, 2006 (12). 
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Nucleotide-binding oligomerization domain-like receptors (NLRs) 
 Although the key function of TLRs in innate immunity is apparent and is 
supported by a rich and dense literature, many other observations have indicated 
the possibility that all features of the host response to pathogens cannot only be 
accounted for by TLRs alone, but also by NLRs as the cytoplasmic counterparts 
(19).  The mammalian NLR family is composed of more than 20 members whose 
defining feature is a modular domain organization of a C-terminal leucine-rich 
repeat (LRR) domain, a central nucleotide-binding Naip, CIITA, HET-E and TP-1  
(NACHT) domain and an N-terminal protein-protein-interaction domain 
composed of a caspase activation and recruitment domain (CARD), pyrin 
domain, or baculovirus ‘inhibitor of apoptosis’ repeat (Bir) domain (Figure 4). 
Studies have shown that several NLRs can detect bacterial molecules through 
mechanisms that remain poorly understood. Nevertheless, studies have 
indicated that many NLRs are necessary sensors of specific PAMPs, even 
though it is unclear if NLRs directly bind to the PAMPs they detect. The first 
NLRs reported to have a direct function as intracellular pattern recognition 
molecules were nucleotide-binding oligomerization domain (NOD) 1 and NOD2; 
both proteins detect distinct substructures from bacterial peptidoglycan (19). 
NOD2 detects muramyl dipeptide, the largest molecular motif common to Gram-
negative and Gram-positive bacteria (20,21). In contrast, NOD1 senses 
peptidoglycan containing meso-diaminopimelic acid, which is more commonly 
found in Gram-negative bacteria (22,23). 
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Figure 4. Nucleotide-binding oligomerization domain-like receptors (NLRs).  
The NLRs are characterized by three distinct domains: an N-terminal effector 
domain, which can be a pyrin domain(PYD), a CARD or a Bir domain; a central 
NACHT domain (NACHT stands for domain present in Naip, CIITA, HET-E (plant 
het product involved in vegetative incompatibility) and TP-1 (telomerase-
associated protein1)) and a C-terminal LRR domain thought to constitute the 
microbe-sending portion. Figure taken from Fritz et al, 2006 (19). 
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 Among the large number of NLR family members, the functions of NOD1 and 
NOD2 have been studied the most. Both NOD1 and NOD2 share the same 
characteristic where they contain N-terminal CARD domains. NOD1 and NOD2 
detect γ-D-glutamyl-meso-diaminopimelic acid (iE-DAP) and muramyl dipeptide 
(MDP), found in bacterial peptidoglycan, respectively (Figure 5). Consistently, 
macrophages lacking either NOD1 or NOD2 fail to produce cytokines in response 
to the corresponding ligands (24). Ligand binding to NOD1 and NOD2 causes 
their oligomerization and results in NF-κβ activation through the recruitment of 
RIP2/RICK, a serine/threonine kinase, to the NODs via their respective CARD 
domains by hemophilic interactions (12). 
 Infection with bacteria induces activation of caspase-1, which catalyzes 
the processing of pro-IL-1β to produce the mature cytokines. A complex of 
proteins responsible for these catalytic processes has been purified and 
designated the inflammasome (Figure 5). The inflammasome consists of 
caspase-1; caspase-5; apoptosis-associated speck-like protein containing a 
CARD (ASC); and members of the NALP family, which are pyrin-domain-
containing proteins that also contain NLRs. ASC is an adaptor protein that 
contains a pyrin domain and a CARD. NALPs recruit ASC through a homotypic 
interaction between the pyrin domains, and ASC in turn recruits caspase-1 via its 
CARD, leading to the activation of IL-1β and IL-18 processing.  
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Figure 5. Cytoplasmic NLRs and their signaling.  
NLRs recognize bacterial proteins in the cytoplasm and trigger signaling 
pathways. NOD1 and NOD2 recognize iE-DAP and MDP, respectively, and 
activate NF-κβ via RIP2/RICK. MDP is also recognized by NALP3, which forms 
an inflammasome comprised of ASC, CARDINAL, and caspase-1. Activated 
caspase-1 cleaves pro-IL-1β for the maturation of IL-1β. Figure taken from Akira, 
Uematsu, and Takeuchi, 2006 (12). 
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OME and innate immunity 
 Resistance to infection of the middle ear is the basis for avoidance of 
OME and, if infection ensures, recovery from middle ear disease. As at other 
locations, such resistance entails a cooperative response involving innate and 
adaptive immunity. However, as very few lymphocytes are found in the healthy 
middle ear, innate immunity presumably mediates the initial host response to and 
defense against infection (2). This allows the middle ear to clear many infections 
rapidly, before significant cognate immune response has the opportunity to 
develop. This is especially important in the middle ear, as adaptive immunity 
appears to be poorly sensitized by antigen that is first presented at this site (2).  
 One of the most common isolated pathogens of otitis media, 
Haemophilus influenzae, contains molecular patterns that sere as ligands for 
several TLRs. Peptidoglycans and peptidoglycan-associated proteins, such as 
outer membrane protein P6, are ligands for TLR2 (25), which frequently forms 
heterodimers with TLR1 or TLR6. Lipooligosaccharide, closely related to LPS, 
activates cellular signals via TLR2 and TLR4 (26). Whereas middle ear 
responses to these TLR2 and TLR4 ligands have long been recognized, the role 
played by TLR receptors in infection-mediated OME pathogenesis has only 
recently been addressed. 
 NOD1 and NOD2 are primarily involved in mediating antibacterial 
defenses (27). These PRRs may play critical roles in antibacterial defenses 
because both NOD1 null and NOD2 null mice show increased susceptibility to 
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infection with certain gastrointestinal bacteria (28). These cytoplasmic receptors 
play an important role following infection of the middle ear by pathogens that 
avoid recognition by TLRs. In the absence of infection, most cytoplasmic 
receptors are present at low concentrations inside the cell, but they are induced 
by proinflammatory cytokines and pathogen invasion (28).  
 Recent studies on PRR expressions in pediatric patients with OME 
have reported that the decreased expression of PRRs may be associated with 
increased susceptibility to OME (28,29). Even though no mutations had been 
found in TLR-2 and -4, which were expressed in all isolated samples of middle 
ear fluids, levels of TLR-9 and NOD-1 mRNAs were significantly lower in 
individuals with recurrent OME (29). Based on this, we hypothesized that there 
may be a difference in expression level of PRRs dependent on the clinical states 
of OME. Thus, in the present study we focused on the innate immune response 
in OME patients according to the characteristics of effusion fluids, presence of 
bacteria in exudates, and the frequency of ventilation tube insertion. Specifically, 
in the innate immune response in OME, we addressed the expressions of TLR-2, 
-4, -5, -9, NOD-1, and -2, which may play important roles in bacterial infection.  
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MATERIALS AND METHODS 
 
Subjects 
The study sample consisted of 46 pediatric patients who visited the 
Department of Otorhinolaryngology at Kyung Hee University Hospital in Seoul, 
South Korea from January 2008 to April 2010 and underwent ventilation tube 
insertion for chronic OME. OME was diagnosed by the presence of an amber-
colored tympanic membrane on otoscopic examination and by the presence of B- 
or C-type tympanograms as shown by impedance audiometry. Surgery was 
performed on chronic OME patients who did not show improvement after 2 
weeks of antibiotic treatment and in patients who, after a 2–3 month follow up, 
showed progressive retraction of the eardrum or progression of hearing loss as 
shown by an increase in pure tone threshold. 
 
Informed Consent 
We received prior permission with written informed consent from the 
patients’ parents or guardians for using patient samples, and the purpose of the 
experiment was also explained to them. Children who were suspected of having 
acute otitis media, head and neck anomalies, systemic diseases, or congenital or 
acquired immunodeficiencies were excluded from participation. 
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Procedure 
A tympanostomy tube was inserted after a radial shaped incision was 
made in the anterior inferior quadrant of the tympanic membrane. Prior to 
surgery, the external auditory canal was washed with potadine solution, and 
middle ear effusion fluid (MEEF) was collected using a collector (Xomed Treace 
Products, Jacksonville, FL, USA) by aseptic procedures, taking care to avoid 
bleeding. Each effusion fluid sample was collected using sterilized cotton swabs, 
added to Stuart transport medium, and used to inoculate blood agar medium and 
thioglycollate liquid medium. All cultures were incubated for at least 24 hours at 
35°C, and the resultant bacteria were identified by Gram-staining and 
biochemical analyses.  
 
Polymerase Chain Reaction 
 Total RNA was extracted from effusion using the RNA-Bee solution kit 
(Tel-Test, Friendswood, TX, USA) following the manufacturer’s protocol. First-
strand cDNA synthesis was performed by reverse transcription in a total volume 
of 20 µl reaction mixture containing 1 µg of RNA, 1x reaction buffer, 1 mM dNTP, 
5 µM random primers, 20 units RNase inhibitor, and 20 units AMV reverse 
transcriptase (Promega, Madison, WI, USA). The reaction mixture was incubated 
at 42°C for 1 h, terminated by heating at 95°C for 5 min. TLR-2, -4, -5, -9, NOD-1 
and -2 primers are shown in Table 1.  
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Name Sequences annealing 
temperature 
product 
size 
TLR 2 
 
TLR 4 
 
TLR 5 
 
TLR 9 
F:5’-GCCAAAGTCTTGATTGATTGG-3’ 
R:5’-TTGAAGTTCTCCAGCTCCTG-3’ 
F:5’-TGGATACGTTTCCTTATAAG-3’ 
R:5’-GAAATGGAGGCACCCCTTC-3’ 
F:5’-CTAGCTCCTAATCCTGATG-3’ 
R:5’-CCATGTGAAGTCTTTGCTGC-3’ 
F:5’-CCCTCAACTTCACCTTGGATCT-3’ 
R:5’-CCACATATGGCCCAGTGCA-3’ 
64 
 
55 
 
55 
 
64 
347 
 
507 
 
438 
 
428 
NOD 1 F:5’-TGATGCTGTTTCTGCCTCTC-3’ 
R:5’-AATTTGACCCCTGCGTCTAG-3’ 
56 374 
NOD 2 F:5’-AGCCATTGTCAGGAGGCTC-3’ 
R:5’-CGTCTCTGCTCCATCATAGG-3 
56 319 
β-actin F;5’-CTTCTACAATGAGCTGCGTG-3’ 
R;5’-TCATGAGGTAGTCAGTCAGG-3’ 
55 305 
 
Table 3. Primers utilized for real-time RT-PCR. 
 
Abbreviations - RT-PCR: real time-polymerase chain reaction; TLR: Toll-like 
receptor; NOD: nucleotide-binding oligomerization domain. 
 
  
Real-time polymerase chain reaction (PCR) was performed using a 
Chromo4 Detector real-time system (Bio-Rad, Hercules, CA, USA) with the 
SsoFast EvaGreen supermix (Bio-Rad). PCR was performed with 2 µl of cDNA in 
a 20-µl reaction mixture of 10 µl SsoFast EvaGreen supermix, 2 µl primers and 6 
µl PCR grade water. The reaction parameters were as follows: denaturation at 
95°C for 30 sec followed by 45 cycles at 95°C for 5 sec, 55°C to 64°C for 12 sec. 
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The crossing point of TLR-2, -4, -5, -9, NOD-1, or -2 with β-actin was applied to 
the formula, 2-(target gene- ß actin) and the relative amounts were quantitated. 
Difference of PRRs expression level by presence of bacteria, ventilation tube 
insertion rate, and effusion fluid character was assessed. 
 
Statistical Analysis 
Between group differences in PRRs expression, bacterial culture results, 
and frequency of ventilating tube insertion were compared using the Mann-
Whitney U test. The relationship between the expression level of PRRs and 
characteristics of effusion fluid was analyzed by the Kruskal Wallis test. All 
statistical calculations were performed using SPSS 11.5 for Windows, and P-
values lower than 0.05 were considered statistically significant.  
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RESULTS 
 
The study sample consisted of 46 children with OME, 35 boys and 11 girls 
with a mean age 4.7 (± 2.1) years. Effusion fluids from all 46 of these patients 
were collected during the insertion of tympanostomy tubes. TLR-2, -4, -5, -9, 
NOD-1, and -2 were expressed in all middle ear exudates; TLR-9 showed the 
highest expression level, followed by TLR-2, TLR-4, TLR-5, NOD-2, and NOD-1. 
The characteristics of effusion fluid presented 17 mucoid cases, 16 serous 
cases, 10 mucopurulent cases and 3 purulent cases. There were no significant 
differences among mRNA levels of TLR-2, -4, -5, -9, NOD-1, and -2 regardless of 
their effusion characteristics (P>0.05, Table 4). 
 
  
mucoid 
 
 
serous 
 
mucopurulent 
 
purulent 
 
p-value 
TLR2 0.061±0.051 0.168±0.218 0.151±0.160 0.197±0.151 0.248 
TLR4 0.034±0.024 0.083±0.072 0.091±0.061 0.049±0.018 0.064 
TLR5 0.034±0.038 0.055±0.051 0.060±0.052 0.051±0.013 0.551 
TLR9 0.154±0.149 0.298±0.268 0.099±0.105 0.183±0.107 0.140 
NOD1 0.003±0.002 0.008±0.016 0.005±0.006 0.004±0.003 0.646 
NOD2 0.005±0.003 0.039±0.070 0.017±0.013 0.013±0.001 0.297 
 
Table 4. Expression of PRRs according to characteristics of exudates. 
 
PRRs: Pattern recognition receptors; TLR: Toll-like receptor; NOD: nucleotide-
binding oligomerization domain. 
 
 26 
Of the 46 samples examined, 31 (67.4%) were negative for growth of 
bacteria, whereas the remaining 15 (32.6%) showed bacterial growth from the 
effusion fluid. Bacteria were cultured and identified; the bacterial species 
identified were coagulase-negative Staphylococcus (CNS), methicillin-resistant 
Staphylococcus aureus (MRSA), Streptococcus pneumonia, Micrococcus spp., 
Pseudomonas aeruginosa, methicillin-sensitive Staphylococcus aureus, 
Streptococcus viridians, and Acinotobacter iwoffi (Table 5).  
 
 
Bacteriology Number (%) 
No growth 31 (67.4%) 
CNS 3  (6.5%) 
MRSA 2  (4.3%) 
Streptococcus pneumoniae 2  (4.3%) 
Micorococcus spp. 2  (4.3%) 
Pseudomonas aeruginosa 2  (4.3%) 
Staphylococcus aureus 2  (4.3%) 
Streptococcus viridans 1  (2.1%) 
Acinotobacter Iwoffi 1  (2.1%) 
Total 46 
 
Table 5. Culture results from middle ear effusion fluid. 
 
CNS: coagulase-negative staphylococci; MRSA: methicillin-resistant 
staphylococcus aureus. 
 
We observed expressions of TLR-2, -4, -5, -9, NOD-1, and -2 mRNAs in 
all effusion samples. We observed no differences between the presence of 
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bacteria in exudates and the expression levels of TLR-9, NOD-1, and NOD-2 
mRNA (p>0.05), (Table 6). In addition, expression levels of PRRs mRNA were 
not associated with the frequency of ventilating tube insertion (p>0.05), (Table 7). 
Similarly, there were no differences between frequencies of ventilation tube 
insertion and expression levels of PRRs, regardless of the presence of bacteria 
in middle ear fluid (p>0.05), (Table 8).  
 
 
 
 Non-bacterial 
detection  
Bacterial  
detection   
p-value 
TLR2 0.123±0.166 0.113±0.106 0.822 
TLR4 0.069±0.063 0.058±0.066 0.565 
TLR5 0.043±0.048 0.059±0.067 0.876 
TLR9 0.182±0.210 0.241±0.267 0.691 
NOD1 0.006±0.011 0.004±0.003 0.139 
NOD2 0.022±0.047 0.007±0.005 0.089 
    
 
Table 6. Expression of PRRs according to bacterial culture results in 
effusion fluid.  
 
PRRs: Pattern recognition receptors; TLR: Toll-like receptor; NOD: nucleotide-
binding oligomerization domain. 
 
 
 
 
 
 
 28 
 Once   Twice or more  p-value 
TLR2 0.115±0.155 0.136±0.090 0.525 
TLR4 0.066±0.066 0.063±0.043 0.449 
TLR5 0.044±0.051 0.072±0.061 0.128 
TLR9 0.175±0.217 0.183±0.196 0.437 
NOD1 0.006±0.012 0.004±0.006 0.868 
NOD2 0.021±0.049 0.013±0.008 0.811 
 
 
Table 7. Expression of PRRs according to the frequency of ventilating tube 
insertion.  
 
PRRs: Pattern recognition receptors; TLR: Toll-like receptor; NOD: nucleotide-
binding oligomerization domain. 
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Table 8. Expression of PRRs according to culture results and the frequency 
of ventilating tube insertion.  
 
PRRs: Pattern recognition receptors; TLR: Toll-like receptor; NOD: nucleotide-
binding oligomerization domain. 
 
 
 
 
 Culture (+) Culture (-) p-
value 
 Once Twice or 
more 
Once Twice or more 
TLR2 0.113±0.162 0.107±0.081 0.122±0.145 0.196±0.093 0.821 
TLR4 0.070±0.074 0.056±0.044 0.056±0.043 0.077±0.047 0.898 
TLR5 0.046±0.055 0.056±0.069 0.041±0.045 0.099±0.042 0.300 
TLR9 0.133±0.167 0.180±0.192 0.217±0.267 0.195±0.198 0.476 
NOD1 0.008±0.015 0.004±0.005 0.004±0.005 0.008±0.006 0.883 
NOD2 0.017±0.049 0.007±0.008 0.018±0.023 0.036±0.038 0.811 
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DISCUSSION 
 
 Otitis media with effusion (OME) is a disease in which secreted fluid 
accumulates in the middle ear cavity and is a major cause of hearing loss in 
children (30,31). Among the possible causes of otitis media are: Eustachian tube 
dysfunction, bacterial or viral infection, family history, and allergies, with 
inflammatory reactions induced by pathogen stimulation thought to be important 
(32). Persistent infection can lead to the accumulation of inflammatory mediators, 
as well as their secretion into effusion fluid. Therefore, analysis of effusion fluid 
could be important in understanding the pathologic mechanism of OME. Although 
the immunological etiology of recurrent OME has been investigated thoroughly, it 
is not yet clear when the innate immunity system first reacts with pathogens 
invading the middle ear cavity. 
 Invading pathogens are recognized by PRRs, a class of proteins, which 
are distributed in extracellular, membrane, and cytoplasmic compartments. The 
major extracellular PRRs, including the complement components may be the first 
to encounter invading pathogens, opsonizing them for clearance by 
phagocytosis, a process mediated by membrane-associated phagocytic 
receptors. The major membrane-associated PRRs, the TLRs, are closely related 
type 1 transmembrane proteins that transduce signals in response to microbial 
intruders such as bacteria, fungi, protozoa and viruses. Although TLRs are 
crucial for innate immunity, they are also required for the induction of adaptive 
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immune responses that combat many infections. Pathogens that escape these 
two detection systems may be recognized by cytoplasmic PRRs, NLRs, which 
mediate antibacterial defenses (33). 
 These receptors in different cellular compartments such as on the cell 
surface, and in the endosomes, lysosomes or cytoplasm have been shown to 
differ in intracellular localization, recognition of different pathogenic motifs, and 
cell signaling (34). For example, TLR-2, -4, and -5 are located on the cell surface, 
TLR-9 is present on endosomal and lysosomal membranes, and NOD-1 and -2 
receptors are located in the cytoplasm. TLR-2 and -4 have been reported to 
recognize pathogenic bacteria, whereas TLR-2 is the receptor for the cell wall 
components of Gram-positive bacteria including peptidoglycans, lipoteichoic acid 
and lipoproteins, and TLR-4 binds to the toxic pneumolysin ligand produced by 
Gram-positive bacteria, as well as binding to lipopolysaccharide (LPS), the major 
component of Gram-negative bacterial cell walls (35-37). Both NOD-1 and -2 
have cytoplasmic caspase-recruiting effector domains and recognize 
peptidoglycan fragments. NOD-1 recognizes Gram-negative bacteria, whereas 
NOD-2 recognizes both Gram-positive and Gram-negative bacteria (38).  
 Inflammatory diseases caused by the abnormal immune control of 
nosocomical infections may be due to some problem with expression levels of 
PRRs. Despite the fact that PRR may play a crucial role in the innate immune 
response, little is known about how and when the innate immune system reacts 
with pathogens invading the middle ear cavity in pediatric patients with OME. 
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Thus, we not only assayed the expressions and relationships among PRRs, but 
we also aimed to discern whether there were differential expression levels of 
PRRs according to bacterial infection.   
 TLRs serve a sentinel role in early detection for invading pathogens so 
that the host can activate local inflammation through the expression of innate 
immune mediators such as the complement cascade. When there is a mutation 
in TLRs, not only otitis media, but periodontitis and osteomyelitis can also occur 
due to the reduced ability for bacterial cell wall recognition and an increased 
susceptibility to bacterial infection (39-43). TLR-2 and -4 were reported to be 
involved in defense mechanism of the middle ear cavity and in the bacterial 
alleviation or clearance of OME. Genetic mutation of TLR-2 or -4 was also 
reported to increase the susceptibility for bacterial infection in OME (44,45). In 
our study, we confirmed that TLR-2 and -4 were expressed in exudates of OME. 
TLR-5 and -9 that are related to the response to bacterial infection were also 
expressed in the middle ear effusion. These results imply that the difference of 
PRRs expression levels may be closely associated with the development of 
OME. 
The role of cytoplasmic receptors becomes critical when pathogens that 
have the ability to escape from TLR recognition enter the body (33). The 
expression levels of many cytoplasmic receptors stay low under normal 
conditions, but when pathogens invade and pro-inflammatory cytokines are 
manifested, their expressions are highly induced. Although cytoplasmic receptor-
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associated diseases have been described, detailed causes and treatment 
methods have not yet been determined. Failure of PAMP recognition or 
transformation of the function of cytoplasmic receptors by mutations in domains 
that send a signal lead abrogate immune reactions, even after infection by 
pathogens. In contrast these aberrant responses may provoke unnecessary 
inflammatory responses and inflammatory diseases by sending excess signals. 
For example mutations in NOD have been associated with chronic inflammatory 
diseases such as Crohn’s disease and Blau syndrome (46,47). Our results 
showed simultaneous expression of the cytoplasmic receptors NOD-1 or NOD-2 
along with the TLRs in all cases regardless of bacterial presence or species. This 
suggests that PRRs function cooperatively rather than individually in OME.  
Previous studies on the immunological status of the host in otitis media 
have asserted that the independent local immunity of the middle ear cavity is one 
of the main causes of OME (48,49). The close relationship between bacterial 
infection and the innate immune response of OME can be deduced because 
bacteria were detected in exudates of the middle ear cavity, and children with a 
higher prevalence for upper airway infection were more likely to develop OME. 
These findings suggest that bacterial infection probably plays an important role in 
the development of OME (50).  
Some have presented an association between the level of antibody in the 
middle ear effusions and bacterial infection, and suggested that the higher 
concentrations of immunoglobulin in middle ear effusions from patients with 
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acute otitis media are associated with lower detection rates of bacteria. Other 
research has showed that the serum levels of immunoglobulin from children with 
OME may be closely related to bacterial infection (49). These studies led to the 
examination of the relationship between bacterial infection and the acquired 
immune response in otitis media (9, 49). However, there was no correlation 
between effusion Ig concentration and the presence of bacteria in OME. In order 
to determine the relationship between bacterial infection and innate immunity, the 
expression levels of PRRs were compared between subjects who were detected 
of bacteria and those who were not detected of bacteria in exudates, and we 
found no relationship between bacterial infection and PRRs. However, it is still 
important to note the possible involvement of PRRs in immune response to otitis 
media, since PRRs were expressed in all exudate samples from otitis media 
regardless of bacterial detection.  
 
Study Limitations 
There are some limitations in this study. First, although our study group 
included patients with OME, all had normal immunity and were in a chronic, not 
an acute, state; and the study did not include children with early stage OME. 
Second, antibiotics had been used for 2 weeks to treat early stage of symptoms 
in all patients. Third, 67.4% showed negative growth despite bacterial infection 
possibly due to the use of various antibiotics prior to myringotomy and insertion 
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of ventilation tubes, creating a bacteriostatic condition and delaying the 
proliferation and growth of pathogens. Fourth, only the middle ear effusion was 
tested for bacteria and not the mucous membrane of the middle ear. The exudate 
contains only a few partially exfoliated mucosal epithelial cells and inflammatory 
cells; this would not fully reflect the immune cells in the middle ear mucosa 
during infection, but we obviously could not collect the middle ear mucosa of 
patients due to ethical issues. Finally, as the exudates used in this study were 
collected during surgery 2-3 months after the occurrence of the initial onset of 
otitis media, our study may not fully reflect the direct immune response in the 
middle ear cavity. PRRs were expressed in all exudates samples of otitis media 
regardless of bacterial detection. Our study showed similar PRRs expression 
values between the group that received reoperation from the recurrence of OME 
and the group with only one operation. This suggests that innate immunity may 
be involved in the middle ear cavity irrespective of the recurrence of OME.  
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CONCLUSION 
 
This study confirmed that all exudates of OME patients showed some 
level of PRR expression related to innate immune response regardless of 
characteristics of effusion fluid, presence of bacteria in exudates, or frequency of 
ventilation tube insertion. Thus, variable expression levels of PRRs may be an 
important indicator for innate immune responses in patients with OME. 
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